Kepler Vision Technologies Unveils Innovative Kepler Night Nurse Lying Position Detection to Combat Pressure Ulcers

Kepler Vision Technologies, a pioneering leader in healthcare AI solutions, is proud to introduce its ground-breaking feature, the Kepler Night Nurse Lying Position Detection. This innovative technology, offers a powerful solution to the pressing issue of pressure ulcers, commonly known as bedsores.

Pressure ulcers pose a significant threat to patients, with statistics indicating that over 60 percent of patients face the risk of developing these painful sores, with approximately 250 people losing their lives each year due to complications arising from pressure ulcers, according to recent research.

The Kepler Night Nurse Lying Position Detection augments the existing suite of features, including fall detection and prevention modules. This new addition is designed to empower healthcare professionals in their tireless efforts to prevent and mitigate the occurrence of bedsores.

Pressure ulcers result from various factors, primarily prolonged pressure on the skin or shearing forces. Vulnerable patients include elderly residents in nursing homes and individuals recovering from surgery who are confined to their beds. Given that pressure ulcers often heal slowly and are prone to recurrence, prevention is paramount.

Healthcare providers employ multiple interventions to avert pressure ulcers, with repositioning patients as a central strategy. Additionally, healthcare staff assess mattress suitability and maximize bed capabilities. However, these interventions demand considerable time and attention from healthcare workers. Some patients are unable to change positions independently, potentially disrupting their vital sleep, leading to fatigue and restlessness.

The Kepler Night Nurse Lying Position Detection empowers healthcare professionals with critical information about patients at an elevated risk of developing pressure ulcers. By continuously monitoring patients’ sleep positions, the Kepler module offers timely insights, indicating when manual position adjustments are required.

This revolutionary feature not only saves a significant amount of time—manual patient turning can take up to 20 minutes and must occur every 2 to 4 hours—but also reduces healthcare costs. The financial burden associated with caring for patients with pressure ulcers ranges from tens to hundreds of euros per patient per day, depending on the severity of the condition.

Kepler Vision Technologies is dedicated to transforming healthcare by leveraging advanced AI solutions, and the Kepler Night Nurse Lying Position Detection is a testament to the commitment to enhancing patient care, alleviating the workload of healthcare professionals, and ultimately improving the quality of life for those under their care.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version